Stent Thrombosis In Acute Coronary Syndromes

Official Title: “Contemporary Treatment Of Stent Thrombosis In Acute Coronary Syndromes”

The purpose of this study is to better understand what treatment methods result in the best outcomes for patients who have heart attacks due to blood clots forming within stents.

This is a multicenter registry that examines treatment strategies and outcomes in patients who present with acute coronary syndrome (ACS) due to stent thrombosis in the coronary arteries. This study will take place at potentially 8 medical centers throughout the State of California. A total of 800 patients will be enrolled into the registry, 100 patients from each of the eight participating California medical centers. UC Davis will serve as the core lab for this study.

Eligible subjects, patients who present to the hospital (medical center) with ACS due to stent thrombosis and receive a cardiac catheterization to treat the stent thrombosis, will be included in the retrospective analysis of this cardiac condition. Subjects who expire in hospital due to ACS with stent thrombosis will also be included in the retrospective analysis of this clinical registry. Patients, who consent for approval, will become eligible to participate in the 3-year prospective follow-up phase of the clinical registry.

These patients will be followed for three years to learn more about long term clinical outcomes for this disease state.

There are no specific/special procedures required for this clinical registry. This is a registry for data collection only to correlate prescribed medical care with individual short- and long-term clinical outcomes.

Primary Measures

• To describe current real world practice in the treatment of ACS due to stent thrombosis.
  • Time Frame: 3 years
    Safety Issue?: No

Secondary Measures

• To describe early and long term follow up of patients who are treated for ACS due to stent thrombosis.
  • Time Frame: 3 years
    Safety Issue?: No

Inclusion Criteria:

• Subject's age range will be ≥ 18 years old.
• Subjects will have an existing drug-eluting or bare metal stent.
• Subjects will have presented to the Medical Center with Acute Coronary Syndrome due to stent thrombosis as identified via cardiac catheterization.

Exclusion Criteria:

• Inability to consent/declined to participate in the prospective arm of the clinical registry.

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Lead Investigator: University of California, Davis Other

Overall Clinical Trial Officials and Contacts

Jason Rogers, MD Principal Investigator University of California, Davis  

Information obtained from ClinicalTrials.gov on February 12, 2012

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00931502

Study ID Number: 200816184

ClinicalTrials.gov Identifier: NCT00931502

Health Authority: United States: Institutional Review Board